Origin, a 3D printing specialist for medical devices, completed clinical trials and validation of the company’s 3D-printed nasopharyngeal swabs for use in COVID-19 test kits.

U.S. states pleaded with the Trump administration to coordinate a national response to the coronavirus outbreak, saying patchwork measures enacted by state and local authorities were insufficient to confront the coast-to-coast emergency.

A Zika vaccine Sanofi SA dropped during September 2017 under political pressure over pricing produced strong responses in more than 90 percent of those taking part in an early-stage clinical trial, U.S. researchers reported.

French drugmaker Sanofi struck an R&D deal with the U.S. Army to speed up the development of a vaccine against the mosquito-borne Zika virus.